Kyle Mikson

Stock Analyst at Canaccord Genuity

(0)
# 4868
Out of 5,370 analysts
103
Total ratings
21.15%
Success rate
-21.25%
Average return
23 Stocks
Name Action PT Current % Upside Ratings Updated
ILMN Illumina
Maintains: Hold
87 99
90.09 9.89% 11 Jun 11, 2025
AKYA Akoya Biosciences
Maintains: Hold
2 2
1.27 -14.96% 5 May 19, 2025
GRAL GRAIL
Maintains: Strong Buy
32 43
42.55 1.06% 2 May 14, 2025
BDSX Biodesix
Maintains: Buy
3 2
n/a n/a 4 May 14, 2025
XGN Exagen
Maintains: Strong Buy
7 8
7.52 6.38% 3 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
15 12
6.12 96.08% 6 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
18 15
11.03 35.99% 8 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 37
19.23 92.41% 4 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
60 65
49.13 32.3% 7 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
170 150
126.08 18.97% 3 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 3
1.38 117.39% 8 Apr 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
180 195
168.2 15.93% 8 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 3
1.26 138.1% 4 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
2 1
1.77 -43.5% 3 Nov 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
95 75
53.29 40.74% 9 Nov 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
3 5
n/a n/a 3 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
26
n/a n/a 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 2
n/a n/a 4 Nov 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
3
n/a n/a 4 Sep 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
3 2
0.72 177.78% 2 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
50
0.63 7709.52% 1 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
19
3.83 396.08% 1 Jan 29, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
150
n/a n/a 1 Jan 29, 2021